Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation

BACKGROUND: Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore the underl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Complement Med Ther
Autors principals: Li, Lin, Yang, Dongli, Li, Jinghao, Niu, Lu, Chen, Ye, Zhao, Xin, Oduro, Patrick Kwabena, Wei, Chun, Xu, Zongpei, Wang, Qilong, Li, Yuhong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158159/
https://ncbi.nlm.nih.gov/pubmed/32293408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-020-02905-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars